Comparison of Inhibitory Effects of Nisin, Glycine, Poly-L-lysine, Magnesium Oxide Nanoparticles and Peganum harmala Extract on Standard and Multidrug-Resistant Pseudomonas aeruginosa

Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 78

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJMM-11-6_008

تاریخ نمایه سازی: 16 مرداد 1402

Abstract:

Background and Aims: Pseudomonas aeruginosa is one of the most important common causes of nosocomial infections that its standard and antibiotic-resistant strains can infect critical body organs such as the lungs and the urinary tract. In this study, inhibitory effects of nisin, glycine, poly-L-lysine, magnesium oxide nanoparticles and hydroalcoholic extract of Peganum harmala were assessed against standard and multidrug-resistant strains of P. aeruginosa. Materials and Methods: MgO nanoparticles with sizes of around ۳۰-۵۰ nm were synthesized via wet chemical method. Their structure were characterized using X-ray diffraction (XRD) analysis and scanning electron microscope (SEM). P. harmala seed extract was prepared by soaking in water-ethanol ۱:۱. Solutions of glycine, poly-L-lysine and nisin were prepared, and sterilized using ۰.۲۲ μm filter. Inhibitory effects of all compounds as inhibition zone diameter (IZD), the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) values were determined according to CLSI guidelines using disk diffusion and broth microdilution methods. Results and Conclusions: No significant inhibitory effects against P. aeruginosa were observed at the highest used concentrations of glycine, poly-L-lysine, MgO nanoparticles and plant extract. Inhibitory effects against both standard and resistant strains were only recorded for nisin with inhibition zone diameter of ۱۰.۳۶, ۱۳.۰۸ mm, MIC of ۶۴, ۱۲۸ μg/mL and MBC of ۲۵۶, ۵۱۲ μg/mL. Nisin as a natural food preservative can be used alone or in combination with current antibiotics to treat diseases caused by P. aeruginosa.

Authors

Hamid Beyzaei

Department of Chemistry, Faculty of Science, University of Zabol, Zabol, Iran

Behzad Ghasemi

Torbat-e Jam Faculty of Medical Sciences, Torbat-e Jam, Iran

Mojtaba Mirzaei

Young Researchers and Elite Club, Mashhad Branch, Islamic Azad University, Mashhad, Iran

Ghasem Sanjarani

Young Researchers and Elite Club, Zahedan Branch, Islamic Azad University, Zahedan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Ferreira M, de Paula GR, Barros RR. Distribution of virulence ...
  • Anderson KA, Schaefer AM, Rice CD. Quantifying circulating antibody activities ...
  • Numberger D, Siebert U, Fulde M, Valentin-Weigand P. Streptococcal Infections ...
  • Campo CH, Martinez MF, Otero JC, Rincon G. Vagino-rectal colonization ...
  • Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae). Microbiol ...
  • Bobadilla FJ, Novosak MG, Cortese IJ, Delgado OD, Laczeski ME. ...
  • Committee Opinion No. ۴۸۵: Prevention of Early-Onset Group B Streptococcal ...
  • Kannika K, Pisuttharachai D, Srisapoome P, Wongtavatchai J, Kondo H, ...
  • Performance Standards for Antimicrobial Susceptibility Testing. ۲۷th ed. Wayne: CLSI; ...
  • Hossein YektaKooshali M, Hamidi M, Mohammad Taghi Razavi Tousi S, ...
  • Lu B, Li D, Cui Y, Sui W, Huang L, ...
  • Kim EJ, Oh KY, Kim MY, Seo YS, Shin JH, ...
  • Melo S, Costa AB, Silva F, Silva N, Tashima CM, ...
  • Lee WT, Lai MC. High prevalence of Streptococcus agalactiae from ...
  • Fazeli Z, Alipour M, Amir Mozafari N, Ghasemi Nejad Y, ...
  • Sharmila V, Joseph NM, Arun Babu T, Chaturvedula L, Sistla ...
  • Assefa S, Desta K, Lema T. Group B streptococci vaginal ...
  • Dashtizade M, Zolfaghari MR, Yousefi M, Nazari-Alam A. Antibiotic Susceptibility ...
  • Nkembe NM, Kamga HG, Baiye WA, Chafa AB, Njotang PN. ...
  • do Nascimento CS, Dos Santos NFB, Ferreira RCC, Taddei CR. ...
  • Le Doare K, Jarju S, Darboe S, Warburton F, Gorringe ...
  • Udo EE, Boswihi SS, Al-Sweih N. Genotypes and virulence genes ...
  • Mengist A, Kannan H, Abdissa A. Prevalence and antimicrobial susceptibility ...
  • Yasini M, Moniri R, Ghorbaali Z, Ansaripour L, Movahedinejad M, ...
  • Wang P, Ma Z, Tong J, Zhao R, Shi W, ...
  • نمایش کامل مراجع